[1] |
孙沫沫, 李剑明.
PET心肌灌注显像及其定量分析的研究进展[J]. 国际放射医学核医学杂志国际放射医学核医学杂志, 2017, 41(6): 423-429.
doi: 10.3760/cma.j.issn.1673-4114.2017.06.008 Sun MM, Li JM. The research progress of myocardial perfusion and its quantitative analysis with PET[J]. Int J Radiat Med Nucl MedInt J Radiat Med Nucl Med, 2017, 41(6): 423-429. doi: 10.3760/cma.j.issn.1673-4114.2017.06.008 |
[2] |
谢文晖, 蔡小佳, 黄钢.
常见心肌灌注显像剂及其显像程序[J]. 实用医学杂志实用医学杂志, 2009, 25(9): 1524-1526.
doi: 10.3969/j.issn.1006-5725.2009.09.077 Xie WH, Cai XJ, Huang G. The current myocardial perfusion imaging agents and its imaging procedures[J]. J Pract MedJ Pract Med, 2009, 25(9): 1524-1526. doi: 10.3969/j.issn.1006-5725.2009.09.077 |
[3] |
Bateman TM.
Advantages and disadvantages of PET and SPECT in a busy clinical practice[J]. J Nucl CardiolJ Nucl Cardiol, 2012, 19(S1): 3-11.
doi: 10.1007/s12350-011-9490-9 |
[4] |
Beanlands RS, Youssef G.
Diagnosis and prognosis of coronary artery disease: PET is superior to SPECT: Pro[J]. J Nucl CardiolJ Nucl Cardiol, 2010, 17(4): 683-695.
doi: 10.1007/s12350-010-9253-z |
[5] |
Stabin MG.
Radiopharmaceuticals for nuclear cardiology: Radiation dosimetry, uncertainties, and risk[J]. J Nucl MedJ Nucl Med, 2008, 49(9): 1555-1563.
doi: 10.2967/jnumed.108.052241 |
[6] |
李帅, 李剑明.
18F标记新型正电子心肌灌注显像剂的研究进展[J]. 中国医学影像技术中国医学影像技术, 2014, 30(6): 926-929.
doi: 10.13929/j.1003-3289.2014.06.036 Li S, Li JM. Progresses of new myocardial perfusion imaging agents labeled with 18F[J]. Chin J Med Imaging TechnolChin J Med Imaging Technol, 2014, 30(6): 926-929. doi: 10.13929/j.1003-3289.2014.06.036 |
[7] |
Maddahi J, Czernin J, Lazewatsky J, et al.
Phase I, First-in-Human Study of BMS747158, a Novel 18F-Labeled Tracer for Myocardial Perfusion PET: Dosimetry, Biodistribution, Safety, and Imaging Characteristics After a Single Injection at Rest[J]. J Nucl MedJ Nucl Med, 2011, 52(9): 1490-1498.
doi: 10.2967/jnumed.111.092528 |
[8] |
Berman DS, Maddahi J, Tamarappoo BK, et al.
Phase Ⅱ Safety and Clinical Comparison With Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging for Detection of Coronary Artery Disease: Flurpiridaz F 18 Positron Emission Tomography[J]. J Am Coll CardiolJ Am Coll Cardiol, 2013, 61(4): 469-477.
doi: 10.1016/j.jacc.2012.11.022 |
[9] |
Purohit A, Radeke H, Azure M, et al.
Synthesis and Biological Evaluation of Pyridazinone Analogues as Potential Cardiac Positron Emission Tomography Tracers[J]. J Med ChemJ Med Chem, 2008, 51(10): 2954-2970.
doi: 10.1021/jm701443n |
[10] |
刘天文, 王帆, 张杰民, 等.
小型猪吹管麻醉方法介绍[J]. 中国比较医学杂志中国比较医学杂志, 2017, 27(4): 68, 88-.
Liu TW, Wang F, Zhang JM, et al. The introduction of blow tube anesthesia for miniature pigs[J]. Chin J Comp MedChin J Comp Med, 2017, 27(4): 68, 88-. |
[11] |
Werner RA, Chen XY, Rowe SP, et al.
Moving into the next era of PET myocardial perfusion imaging: introduction of novel 18F-labeled tracers[J]. Int J Cardiovasc ImagingInt J Cardiovasc Imaging, 2019, 35(3): 569-577.
doi: 10.1007/S10554-018-1469-z |
[12] |
Salata BM, Singh P.
Role of cardiac PET in clinical practice[J]. Curr Treat Options Cardiovasc MedCurr Treat Options Cardiovasc Med, 2017, 19(12): 93-.
doi: 10.1007/s11936-017-0591-x |
[13] |
Salerno M, Beller GA.
Noninvasive assessment of myocardial perfusion[J]. Circ Cardiovasc ImagingCirc Cardiovasc Imaging, 2009, 2(5): 412-424.
doi: 10.1161/CIRCIMAGING.109.854893 |
[14] |
Iskandrian AE, Dilsizian V, Garcia EV, et al.
Myocardial perfusion imaging: Lessons learned and work to be done-update[J]. J Nucl CardiolJ Nucl Cardiol, 2018, 25(1): 39-52.
doi: 10.1007/s12350-017-1093-7 |
[15] |
Yalamanchili P, Wexler E, Hayes M, et al.
Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: A novel PET myocardial imaging agent[J]. J Nucl CardiolJ Nucl Cardiol, 2007, 14(6): 782-788.
doi: 10.1016/J.NUCLCARD.2007.07.009 |
[16] |
Maddahi J, Bengel F, Czernin J, et al.
Dosimetry, biodistribution, and safety of flurpiridaz F 18 in healthy subjects undergoing rest and exercise or pharmacological stress PET myocardial perfusion imaging[J]. J Nucl CardiolJ Nucl Cardiol, 2019, 26(6): 2018-2030.
doi: 10.1007/s12350-018-01484-z |
[17] |
国家药典委员会. 中华人民共和国药典2015年版. 第四部[M]. 北京: 中国医药科技出版社, 2015. Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China 2015. Volume Ⅳ[M]. Beijing: China Medical Science Press, 2015. |
[18] |
Schindler TH, Quercioli A, Valenta I, et al.
Quantitative assessment of myocardial blood flow−clinical and research applications[J]. Semin Nucl MedSemin Nucl Med, 2014, 44(4): 274-293.
doi: 10.1053/j.semnuclmed.2014.04.002 |